Literature DB >> 376713

Cell differentiation in the presence of cytochalasin B: studies on the "switch" to IgG secretion after polyclonal B cell activation.

W van der Loo, E S Gronowicz, S Strober, L A Herzenberg.   

Abstract

Mouse spleen cells were cultured with lipopolysaccharide in conditions that activate both IgM and IgG secretion. Addition of cytochalasin B (CB), an inhibitor of cytokinesis, lead to a high degree of polynucleation, with little effect on Ig secretion. Using cytoplasmic staining with fluorochrome conjugated antisera, we determined the numbers of IgG-containing cells that also contained IgM in their cytoplasm. Such double staining cells were relatively more frequent at early times of the cultures, but at all times single producing cells were in the majority. Addition of CB over the period when the IgG producing cells first appear, lead to a marked increased frequency of double staining, polynucleated cells. This characteristic was stable over a period of at least 42 hr, suggesting that each double staining cell actively synthesized both isotypes. When CB was added after IgG production had started, little increase in the numbers of double staining cells were observed, although polynucleation remained extensive. These data confirm previous findings that the lineage of one cell can produce both IgM and IgG. Furthermore, the results suggest that cells in the process of switching from IgM to IgG go through an asymmetric division leading to one IgM-producing and one IgG-producing daughter cell.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 376713

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Copy choice mechanism of immunoglobulin heavy-chain switch recombination.

Authors:  W Dunnick; J Stavnezer
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

2.  Rearrangements and deletions of immunoglobulin heavy chain genes in the double-producing B cell lymphoma I.29.

Authors:  J Stavnezer; K B Marcu; S Sirlin; B Alhadeff; U Hammerling
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

3.  Successive switching of antibody isotypes expressed within the lines of a B-cell clone.

Authors:  P J Gearhart; J L Hurwitz; J J Cebra
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

4.  Structure of a rearranged gamma 1 chain gene and its implication to immunoglobulin class-switch mechanism.

Authors:  M Obata; T Kataoka; S Nakai; H Yamagishi; N Takahashi; Y Yamawaki-Kataoka; T Nikaido; A Shimizu; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

5.  Optimal strategies in immunology III. The IgM-IgG switch.

Authors:  A S Perelson; B Goldstein; S Rocklin
Journal:  J Math Biol       Date:  1980-11       Impact factor: 2.259

6.  Cyclin-dependent kinases regulate Ig class switching by controlling access of AID to the switch region.

Authors:  Minghui He; Elena M Cortizas; Ramiro E Verdun; Eva Severinson
Journal:  J Immunol       Date:  2015-03-20       Impact factor: 5.422

Review 7.  Molecular bases of genetic diversity and evolution of the immunoglobulin heavy chain variable region (IGHV) gene locus in leporids.

Authors:  Ana Pinheiro; Dennis Lanning; Paulo C Alves; Rose G Mage; Katherine L Knight; Wessel van der Loo; Pedro J Esteves
Journal:  Immunogenetics       Date:  2011-05-20       Impact factor: 2.846

8.  Production of human anti-thyroglobulin in vitro. III. The role of immunoglobulin-bearing cells.

Authors:  G N Beall; S R Kruger
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

9.  Mechanism of protective immunity induced by porin-lipopolysaccharide against murine salmonellosis.

Authors:  S Muthukkumar; V R Muthukkaruppan
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

10.  Multiple myeloma with monoclonal IgG and IgD of lambda type exhibiting, under treatment, a shift from mainly IgG to mainly IgD.

Authors:  T Gallart; J Bladé; J Martínez-Quesada; J Sierra; C Rozman; J Vives
Journal:  Immunology       Date:  1985-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.